Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Reports Fourth Quarter and Full ...
August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years ...
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and ...
August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new ...
Rolling Out5 天
How neurogenic inflammation creates pain patterns
Research reveals howneurogenic connection can directly trigger inflammatory processes, creating pain patterns that challenge ...
New Zealand Science Media Centre5 天
Mental health screening “critical” for chronic pain treatment – Expert Reaction
About 40% of adults with chronic pain have anxiety or depression, according to new overseas research covering data from 50 ...